brain tumor stem cells -targeted IFN-gamma gene therapy (Discovery Genomics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namebrain tumor stem cells -targeted IFN-gamma gene therapy (Discovery Genomics)
Drug Alias Namesleeping beauty transposon-mediated IFN-gamma gene therapy (Discovery Genomics)
ClassificationBiologics
Mechanisms of ActionInterferons stimulants
TargetsInterferons
Therapy Area/IndicationsBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiscovery Genomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiscovery Genomics Inc
Active IndicationsN/A
Inactive IndicationsBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A